Search Results 511-520 of 18223 for Immunode

1. A Study Of Tolododekin Alfa (ANK-101) In Combination With An Anti-PD-1/PD-L1 Antibody In Participants With Advanced Non-Small Cell Lung Cancer - Mayo Clinic

   Human immunodeficiency virus (HIV)-infected participants must be on anti-retroviral therapy (ART) and have well-controlled HIV infection/disease. Resolution ...

2. Anaplastic large cell lymphoma - Symptoms and causes - Mayo Clinic

   Infection with human immunodeficiency virus (HIV). People with HIV have weakened immune systems. That increases the risk of ALK-negative ALCL. Ongoing ...

3. Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck - Mayo Clinic

   History of active primary immunodeficiency; Known history of previous tuberculosis; Active infection including hepatitis B, hepatitis C or human ...

4. A Study of a Personalized Cancer Vaccine Targeting Shared Neoantigens - Mayo Clinic

   Known history of positive test for human immunodeficiency (HIV) or known acquired immunodeficiency syndrome (AIDS) Complete inclusion and exclusion criteria are ...

5. DiGeorge syndrome (22q11.2 deletion syndrome) - Diagnosis and treatment - Mayo Clinic

   https://www.aaaai.org/conditions-treatments/primary-immunodeficiency-disease/digeorge-syndrome. Accessed Dec. 1, 2023. DiGeorge syndrome. Merck Manual ...

6. B-cell lymphoma - Symptoms and causes - Mayo Clinic

   These infections include human immunodeficiency virus (HIV), Epstein-Barr virus, Helicobacter pylori (H. pylori), hepatitis C and others. Complications.

7. A Study of V940 Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in Participants With Non-small Cell Lung Cancer (V940-002) - Mayo Clinic

   * Human immunodeficiency virus (HIV)-infected participants must have well controlled HIV on anti-retroviral therapy (ART). Exclusion Criteria: The main ...

8. A Study of AMG 757 in Participants With Neuroendocrine Prostate Cancer - Mayo Clinic

   Has a diagnosis of immunodeficiency or is receiving systemic steroid therapy (prednisone dose > 10 mg per day or equivalent dose) or any other form of ...

9. Kay L. Medina, Ph.D. - Mayo Clinic Faculty Profiles

   ... immunodeficiency well documented in patients with chronic lymphocytic leukemia (CLL). Dr. Medina's lab recently showed that patients with CLL have impaired ...

10. A Global Phase III Study Of Rilvegostomig Or Pembrolizumab Plus Chemotherapy For First-Line Treatment Of Metastatic Non-squamous NSCLC - Mayo Clinic

    * Active primary immunodeficiency/active infectious disease(s). * Active tuberculosis infection. Participating Mayo Clinic locations. Study statuses change ...